Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Celularity (CELU) Preferred Shares (2025)

Celularity (CELU) has disclosed Preferred Shares for 1 consecutive years, with $2.2 million as the latest value for Q4 2025.

For Q4 2025, Preferred Shares changed N/A year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, changed N/A, while the annual FY2025 figure was $2.2 million, N/A changed from the prior year.
Preferred Shares hit $2.2 million in Q4 2025 for Celularity.
Across five years, Preferred Shares topped out at $2.2 million in Q4 2025 and bottomed at $2.2 million in Q4 2025.